Omeros ROE 2010-2025 | OMER

Current and historical return on equity (ROE) values for Omeros (OMER) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Omeros ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.15B $-0.21B 89.94%
2024-12-31 $-0.16B $-0.18B 117.07%
2024-09-30 $-0.13B $-0.15B 142.93%
2024-06-30 $-0.14B $-0.13B 238.30%
2024-03-31 $-0.12B $-0.07B 543.82%
2023-12-31 $-0.12B $-0.03B -1275.68%
2023-09-30 $0.02B $-0.01B 54.05%
2023-06-30 $0.04B $0.02B 141.38%
2023-03-31 $0.05B $0.06B 303.23%
2022-12-31 $0.05B $0.09B 9600.00%
2022-09-30 $0.20B $-0.05B -1333.33%
2022-06-30 $0.19B $-0.03B -280.14%
2022-03-31 $0.20B $-0.01B -160.00%
2021-12-31 $0.19B $0.02B -109.76%
2021-09-30 $-0.12B $-0.26B 58.22%
2021-06-30 $-0.14B $-0.25B 82.25%
2021-03-31 $-0.14B $-0.22B 96.79%
2020-12-31 $-0.14B $-0.12B 109.38%
2020-09-30 $-0.13B $-0.09B 105.52%
2020-06-30 $-0.11B $-0.16B 78.97%
2020-03-31 $-0.09B $-0.13B 68.88%
2019-12-31 $-0.08B $-0.11B 66.40%
2019-09-30 $-0.08B $-0.14B 63.54%
2019-06-30 $-0.10B $-0.13B 91.82%
2019-03-31 $-0.12B $-0.12B 132.24%
2018-12-31 $-0.13B $-0.10B 185.40%
2018-09-30 $-0.12B $-0.09B 271.19%
2018-06-30 $-0.09B $-0.06B 445.57%
2018-03-31 $-0.07B $-0.03B 348.72%
2017-12-31 $-0.05B $0.00B 218.56%
2017-09-30 $-0.06B $0.01B 170.99%
2017-06-30 $-0.06B $-0.06B 154.60%
2017-03-31 $-0.06B $-0.05B 157.96%
2016-12-31 $-0.07B $-0.04B 181.33%
2016-09-30 $-0.07B $-0.02B 195.68%
2016-06-30 $-0.07B $-0.05B 236.80%
2016-03-31 $-0.08B $-0.04B 458.82%
2015-12-31 $-0.08B $-0.03B 6080.00%
2015-09-30 $-0.08B $-0.01B 1400.00%
2015-06-30 $-0.08B $0.01B 750.00%
2015-03-31 $-0.08B $0.02B 515.25%
2014-12-31 $-0.07B $-0.04B 389.47%
2014-09-30 $-0.06B $-0.03B 431.37%
2014-06-30 $-0.05B $-0.01B 425.00%
2014-03-31 $-0.05B $0.01B 383.67%
2013-12-31 $-0.04B $-0.02B 228.57%
2013-09-30 $-0.05B $-0.02B 311.86%
2013-06-30 $-0.05B $-0.01B 500.00%
2013-03-31 $-0.04B $-0.02B 355.56%
2012-12-31 $-0.04B $-0.01B 371.43%
2012-09-30 $-0.04B $0.00B 400.00%
2012-06-30 $-0.04B $-0.02B 388.89%
2012-03-31 $-0.03B $-0.01B 2480.00%
2011-12-31 $-0.03B $-0.01B -504.35%
2011-09-30 $-0.03B $0.00B -212.24%
2011-06-30 $-0.03B $0.01B -158.82%
2011-03-31 $-0.03B $0.02B -136.36%
2010-12-31 $-0.03B $0.02B -109.09%
2010-09-30 $-0.03B $0.02B -87.22%
2010-06-30 $-0.03B $0.03B -104.17%
2010-03-31 $-0.02B $0.04B -139.39%
2009-12-31 $-0.02B $0.04B -289.66%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.199B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.04
Boston Scientific (BSX) United States $147.560B 37.59
Stryker (SYK) United States $144.011B 30.10
EssilorLuxottica (ESLOY) France $128.708B 0.00
Medtronic (MDT) Ireland $111.928B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.49
ResMed (RMD) United States $36.560B 27.72
Agilent Technologies (A) United States $33.258B 22.04
GE HealthCare Technologies (GEHC) United States $33.082B 15.84
Terumo (TRUMY) Japan $26.680B 34.37
Insulet (PODD) United States $21.438B 84.69
Koninklijke Philips (PHG) Netherlands $21.384B 15.43
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.71
Baxter (BAX) United States $15.713B 11.81
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.94
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.47
Perrigo (PRGO) Ireland $3.664B 9.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.31
ICU Medical (ICUI) United States $3.250B 24.18
Envista Holdings (NVST) United States $3.127B 26.73
GN Store Nord (GNNDY) Denmark $2.263B 19.32
QuidelOrtho (QDEL) United States $1.954B 13.59
LeMaitre Vascular (LMAT) United States $1.833B 41.46
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.67
AdaptHealth (AHCO) United States $1.161B 11.81
Green Thumb Industries (GTBIF) United States $1.048B 23.71
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.80
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.55
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 5.08
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.53
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 61.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.50
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.63
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 6.12
Brainsway (BWAY) Israel $0.206B 55.30
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 15.33
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.37
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 48.64
United-Guardian (UG) United States $0.037B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00